Bullish Case: BMY is +4.9% off its October low and grinding back toward the $62–64 mode where both Helium and market PDFs peak (density ~0.113 at $62–63). Call volume runs 37% above puts, bullish risk is 44% higher across tenors, and the 11/07 near-term IV (50.7% market vs 38.1% Helium) should compress after the imminent catalyst. With $61.7 spot just above VWAP, mean-reversion toward $63–65 is the base path.

Bearish Case: The 11/07 IV of 50.7% signals a near-date event with real gap risk, and Helium's 1% IV premium hints realized vol could linger. Thin liquidity (0th percentile volume) widens spreads. The put wing stays rich, the historical return surface shows long-horizon negative skew, and the unresolved patent-cliff narrative caps upside—SPY's downside-rich surface can transmit a macro drawdown via 0.62 correlation.

Potential Outcomes:

1. ~38%: Grind to $62–65 as 11/07 event passes and IV mean-reverts (Helium 38.1% → ~27%).
2. ~20%: Sideways $60–62; flat term structure decays.
3. ~18%: Post-event drop to $58–59 — the PDF's sub-$56 put shoulder justifies the 11/20–11/27 put-wing richness (57%+ IV).
4. ~14%: Macro/SPY risk-off via 0.62 correlation.
5. ~6%: Upside catalyst gap >10%.
6. ~4%: Clinical/regulatory shock >15%.

Trading Oracle: Sign Up to access trading oracle trade ideas.

November 04, 2026